Clinical Trial Update: Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in advanced ampulla of Vater and small intestinal adenocarcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampulla of Vater Adenocarcinoma
• Small Intestinal Adenocarcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ampulla of Vater Adenocarcinoma, Small Intestinal Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-01-18